Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice

Cell Growth and Differentiation

Volumn 8, Issue 2, 1997, Pages 121-131

  Shick, Lawton ^a,b   Carman, Julie H ^b   Choi, John K ^b,c   Somasundaram, Kumaravel ^a,b,c   Burrell, Marilee ^d   Hill, David E ^e   Zeng, Yi Xin ^a,b,c   Wang, Yisong ^f   Wiman, Klas G ^f   Salhany, Kevin ^a,b   Kadesch, Thomas R ^b,c   Monroe, John G ^b   Donehower, Lawrence A ^g   Ei Deiry, Wafik S ^a,b,c  

^a Laboratory of Molecular Oncology and Cell Cycle Regulation   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Oncogene Science Inc   (United States)

^e Oncogene Research Products   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; DNA BINDING; ENHANCER REGION; GENE CLUSTER; GENE REARRANGEMENT; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; TUMOR CELL CULTURE;

ANIMALS; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; BINDING SITES; BLOTTING, WESTERN; BONE MARROW; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FEMALE; GENES, P53; GENES, REGULATOR; GENOTYPE; GLIOBLASTOMA; IMMUNOGLOBULINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE COUNT; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031027964     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Velculescu, V. E., and EI-Deiry, W. S. Biological and clinical importance of the p53 tumor suppressor gene. Clin. Chem., 42: 858-868, 1996.
2. 2 arrest-dependent immunoglobulin κ light chain gene expression. EMBO J., 14: 1392-1401, 1995.
3. Bogue, M. A., Zhu, C., Aguilar-Cordova, E., Donehower, L. A., and Roth, D. B. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev., 10: 553-565, 1996.
4. Ferradini, L., Gu, H., De Smet, A., Rajewsky, K., Reynaud, C-A., and Weill, J-C. Rearrangement-enhancing element upstream of the mouse immunoglobulin kappa chain J cluster. Science (Washington, DC), 271: 1414-1420, 1996.
5. μ transcription in human precursor B lymphocytes initiates in a unique region upstream of DQ52. Eur. J. Immunol., 25: 257-261, 1995.
6. Wang, Y., Ramqvist, T., Szekely, L., Axelson, H., Klein, G., and Wiman, K. G. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. Cell Growth & Differ., 4: 467-473, 1993.
7. Harvey, M., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., Bradley, A., and Donehower, L. A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet., 5: 225-229, 1993.
8. Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y-P., Pinkel, D., Gray, J., Bradley, A., Medina, D., and Varmus, H. E. Deficiency of p53 accelerates mammary tumorigenesis in Wnt. 1 transgenic mice and promotes chromosomal instability. Genes Dev., 9: 882-895, 1995.
9. hi splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol., 151: 4431-4444, 1993.
10. Sieckmann, D. G., Asofsky, R., Mosier, D. E., Zitron, M., and Paul, W. E. Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J. Exp. Med., 147: 814-829, 1978.
11. Sun, Z., and Kitchingman, G. R. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter. Nucleic Acids Res., 22: 850-860, 1994.
12. Chen, J., Young, F., Bottaro, A., Stewart, V., Smith, R. K., and Alt, F. W. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J., 12:4635-4645, 1993.
13. Fernex, C., Capone, M., and Ferrier, P. The V(D)J recombinational and transcriptions! activities of the immunoglobulin heavy-chain intronic en- hancer can be mediated through distinct protein-binding sites in a transgenic substrate. Mol. Cell Biol., 15: 3217-3226, 1995.
14. Serwe, M., and Sablitzky, F. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J., 12: 2321-2327, 1993.
15. Schlissel, M. S., and Baltimore, D. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell, 58: 1001-1007, 1989.
16. Shaulsky, G., Goldfinger, N., Peled, A., and Rotter, V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA, 88: 8982-8986, 1991.
17. Rotter, V., Aloni-Grinstein, R., Schwartz, D., Elkind, N. B., Simons, A., Wolkowicz, R., Lavigne, M., Beserman, P., Kapon, A., and Goldfinger, N. Does wild-type p53 play a role in normal cell differentiation? Semin. Cancer Biol., 5: 229-236, 1994.
18. Aloni-Grinstein, R., Zan-Bar, I., Alboum, I., Goldfinger, N., and Rotter, V. Wild-type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene, 8: 3297-3305, 1993.
19. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
20. McKinnon, P. J. Ataxia-telangiectasia: an inherited disorder of ionizjng-radiation sensitivity in man. Hum. Genet., 75: 197-208, 1987.
21. Artuso, M., Esteve, A., Bresil, H., Vuillaume, M., and Hall, J. The role of the ataxia telangiectasia gene in p53. WAF1/CIP1(p21)- and GADD45-mediated response to DNA damage produced by ionising radiation. Oncogene, 11: 1427-1435, 1995.
22. Kastan, M. B., Zhan, Q., EI-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell, 71: 587-597, 1992.
23. Mercer, W. E., Shiefds, M. T., Amin, M., Sauve, G. J., Apella, E., Romano, J. W., and Ullrich, S. J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses wild-type p53. Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
24. EI-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Un, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
25. EI-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., and Vogelstein, B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
26. Takemori, T., Mizuguchi, J., Miyazoe, I., Nakanishi, M., Shigemoto, K., Kimoto, H., Shirasawa, T., Maruyama, N., and Taniguchi, M. Two types of μ chain complexes are expressed during differentiation from pre-B to mature B cells. EMBO J., 9: 2493-2500, 1990.
27. Wilson, R. B., Kiledjian, M., Shen, C-P., Benezra, R., Zwollo, P., Dymecki, S. M., Desiderio, S. V., and Kadesch, T. Repression of immunoglobulin enhancers by the helix-loop-helix protein id: implications for B-lymphoid-cell development. Mol. Cell. Biol., 11: 6185-6191, 1991.
28. Palacios, R., and Steinmetz, M. II-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell, 41: 727-734, 1985.
29. Smith, K. J., Johnson, K. A., Bryan, T. M., Hill, D. E., Markowitz, S., Wilson, J. K. V., Paraskeva, C., Peterson, G. M., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA, 90: 2846-2850, 1993.
30. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
31. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Regulation of the specific DNA binding function of p53. Cell, 71: 875-886, 1992.
32. EI-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. Definition of a consensus binding site for p53. Nat. Genet., 1: 45-49, 1992.
33. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res., 17: 6419, 1989.
34. Andrew, S. M., and Titus, J. A. Fragmentation of immunoglobulin M. In: J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology, pp. 2.10.1-2.10.2. New York: John Wiley & Sons, Inc., 1994.
35. Mishell, B. B., and Shiigi, S. M. Preparation of mouse cell suspensions. In: B. B. Mishell and S. M. Shiigi (eds.), Selected Methods in Cellular Immunology. New York: W. H. Freeman & Co., 1980.
36. fgr. J. Immunol., 154: 1919-1929, 1995.
37. Choi, J. K., Shen, C. P., Radomask, H. S., Eckhardt, L. A., and Kadesch, T. E47 activates IgH and TdT loci in non-B cells. EMBO J., in press, 1996.